These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2421657)

  • 1. Neurochemical effects of buspirone in rat hippocampus: evidence for selective activation of 5HT neurons.
    Mennini T; Gobbi M; Ponzio F; Garattini S
    Arch Int Pharmacodyn Ther; 1986 Jan; 279(1):40-9. PubMed ID: 2421657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interaction of the anxiolytic agent buspirone with serotonin and other synaptic receptors in the human brain].
    Korneev AIa; Faktor MI; Chan TB
    Biull Eksp Biol Med; 1988 Jan; 105(1):41-3. PubMed ID: 2892547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of supidimide on brain neurotransmitter systems of rats and mice.
    Hennies HH; Günzler WA; Flohé L
    Arzneimittelforschung; 1984; 34(11):1471-80. PubMed ID: 6084511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurochemical effects of the endocannabinoid uptake inhibitor UCM707 in various rat brain regions.
    de Lago E; Ortega-Gutiérrez S; Ramos JA; López Rodríguez ML; Fernández-Ruiz J
    Life Sci; 2007 Feb; 80(10):979-88. PubMed ID: 17173937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral studies with anxiolytic drugs. IV. Serotonergic involvement in the effects of buspirone on punished behavior of pigeons.
    Witkin JM; Mansbach RS; Barrett JE; Bolger GT; Skolnick P; Weissman B
    J Pharmacol Exp Ther; 1987 Dec; 243(3):970-7. PubMed ID: 2891840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral studies with anxiolytic drugs. III. Antipunishment actions of buspirone in the pigeon do not involve benzodiazepine receptor mechanisms.
    Barrett JE; Witkin JM; Mansbach RS; Skolnick P; Weissman BA
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1009-13. PubMed ID: 2875168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropharmacological profile of buspirone: a non-benzodiazepine anxiolytic with specific mid-brain modulating properties.
    Leonard BE
    Br J Clin Pract Suppl; 1985 May; 38():74-82. PubMed ID: 2862907
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel anxiolytics discriminate between postsynaptic serotonin receptors mediating different physiological responses on single neurons of the rat hippocampus.
    Andrade R; Nicoll RA
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jul; 336(1):5-10. PubMed ID: 2888027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notes on buspirone's mechanisms of action.
    Garattini S; Caccia S; Mennini T
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):19-24. PubMed ID: 6130069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiolytic 5-hydroxytryptamine1A agonists suppress firing activity of dorsal hippocampus CA1 pyramidal neurons through a postsynaptic mechanism: single-unit study in unanesthetized, unrestrained rats.
    Tada K; Kasamo K; Ueda N; Suzuki T; Kojima T; Ishikawa K
    J Pharmacol Exp Ther; 1999 Feb; 288(2):843-8. PubMed ID: 9918598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of gepirone, an aryl-piperazine anxiolytic drug, on aggressive behavior and brain monoaminergic neurotransmission.
    McMillen BA; Scott SM; Williams HL; Sanghera MK
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Apr; 335(4):454-64. PubMed ID: 2439924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurochemical effects of buspirone, a novel psychotropic drug, on the central cholinergic system.
    Kolasa K; Fusi R; Garattini S; Consolo S; Ladinsky H
    J Pharm Pharmacol; 1982 May; 34(5):314-7. PubMed ID: 6123570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential pharmacological properties of GABAA/benzodiazepine receptor complex in dorsal compared to ventral rat hippocampus.
    Sarantis K; Sotiriou E; Papatheodoropoulos C; Matsokis N; Angelatou F
    Neurochem Int; 2008 May; 52(6):1019-29. PubMed ID: 18069090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buspirone enhances [3H]flunitrazepam binding in vivo.
    Oakley NR; Jones BJ
    Eur J Pharmacol; 1983 Mar; 87(4):499-500. PubMed ID: 6133760
    [No Abstract]   [Full Text] [Related]  

  • 15. Down-regulation of benzodiazepine binding to alpha 5 subunit-containing gamma-aminobutyric Acid(A) receptors in tolerant rat brain indicates particular involvement of the hippocampal CA1 region.
    Li M; Szabo A; Rosenberg HC
    J Pharmacol Exp Ther; 2000 Nov; 295(2):689-96. PubMed ID: 11046107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties.
    Hamon M; Fattaccini CM; Adrien J; Gallissot MC; Martin P; Gozlan H
    J Pharmacol Exp Ther; 1988 Aug; 246(2):745-52. PubMed ID: 2457083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties.
    Millan MJ; Hjorth S; Samanin R; Schreiber R; Jaffard R; De Ladonchamps B; Veiga S; Goument B; Peglion JL; Spedding M; Brocco M
    J Pharmacol Exp Ther; 1997 Jul; 282(1):148-61. PubMed ID: 9223550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?
    Jolas T; Schreiber R; Laporte AM; Chastanet M; De Vry J; Glaser T; Adrien J; Hamon M
    J Pharmacol Exp Ther; 1995 Feb; 272(2):920-9. PubMed ID: 7853210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors.
    Peroutka SJ
    Biol Psychiatry; 1985 Sep; 20(9):971-9. PubMed ID: 2862927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The different mechanism of the inhibition by buspirone and its camphorimide analogs of 5-HT3-serotoninergic effects].
    Kharin NA; Abramets II; Komissarov IV; Samoĭlovich IM
    Biull Eksp Biol Med; 1993 Aug; 116(8):167-9. PubMed ID: 7903873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.